Ozempic — Nutrient Associations & Health Patterns
Also known as: Semaglutide (Ozempic, Wegovy, Rybelsus)
Drug Class: GLP-1 receptor agonist
Ozempic is a GLP-1 receptor agonist that may affect nutrient status or medication timing in some contexts. WePattern Pattern Health Intelligence maps evidence-qualified nutrient associations, side effects, and interaction context linked to Ozempic.
Reported Nutrient Associations for Ozempic
Peer-reviewed research reports relationships involving the following nutrients. WePattern surfaces them as evidence-qualified associations; they do not establish deficiency, causation, or a fixed timeline for an individual.
- Vitamin B12
- Folic acid
- Vitamin D
- Zinc
Common Side Effects of Ozempic
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Decreased appetite
- Pancreatitis risk
- Thyroid tumor risk
Key Drug Interactions — Ozempic
Ozempic has 5 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Insulin
- Sulfonylureas
- Other diabetes medications
- Oral medications (delayed absorption)
- Warfarin
Frequently Asked Questions
What nutrient associations are reported for Ozempic?
Ozempic has reported nutrient associations involving Vitamin B12, Folic acid, Vitamin D, Zinc in clinical research. This does not establish that every person will become deficient or that the medication caused an individual result.
Which nutrient relationships are mapped for Ozempic?
WePattern maps reported associations involving: Vitamin B12, Folic acid, Vitamin D, Zinc. The strength, mechanism, dose, duration, and clinical relevance vary, so a clinician or pharmacist should interpret them in context.
What are the side effects of Ozempic?
Common side effects associated with Ozempic include: Nausea; Vomiting; Diarrhea; Constipation; Abdominal pain.